0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
Bharat Biotech International Ltd., Hyderabad (BBIL) had proposed to carry out a Phase- II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers.
Share this article
If you liked this article share it with your friends.they will thank you later
/smstreet/media/post_banners/xxGKIAwRJbiwaAaeLLkj.png)
1 Min read
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
